Method for inducing differentiation of pluripotent stem cells into intestinal epithelial cells
A technology of pluripotent stem cells and intestinal epithelial cells, which is applied in the field of induction of differentiation from pluripotent stem cells to intestinal epithelial cells, can solve problems such as difficult to accurately evaluate pharmacokinetics, observation of drug metabolism enzyme expression and enzyme induction, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0156] Search for low-molecular-weight compounds useful for promoting differentiation / acquisition of function from human iPS cells to intestinal epithelial cells
[0157] The following studies were conducted for the purpose of establishing a method for easily and efficiently producing cells (enterocyte-like cells) exhibiting functions closer to living intestinal epithelial cells.
[0158]
[0159] 1. Method
[0160] (1) cells
[0161] As human iPS cells, Windy (iPS-51) and FF-1 strains were used. Windy is the use of a pan-retrotropic retroviral vector to combine octamer binding protein 3 / 4 (octamer binding protein 3 / 4) (OCT3 / 4), sex determining region Y-box protein 2 (sexdetermining region Y-box 2) (SOX2) , Krupp-like factor 4 (kruppel-like factor 4) (KLF4), V-Myc myelocytomatosis viral oncogenehomolog (avian) (c-MYC) introduction After human embryonic lung fibroblasts MRC-5, human ES cell-like colonies were cloned, provided by Dr. Mei Zeminghong of the National Medical R...
Embodiment 2
[0195] 1. Method
[0196] (1) Differentiation from human iPS cells to intestinal epithelial cells
[0197] Human iPS cells (FF-1) were treated with serum-free medium containing 100 ng / mL recombinant human activin A for 24 hours to initiate differentiation. Then, they were treated for 144 hours in a serum-free medium containing 100 ng / mL recombinant human activin A, 2.5 ng / mL BMP4, 10 ng / mL VEGF, and 5 ng / mL FGF2 to differentiate into endoderm. Then, differentiate into small intestine by culturing for 96 hours in AdvancedDMEM / F-12 containing 2% FBS, 1% GlutaMax, 100 units / mL penicillin G, 100 μg / mL streptomycin sulfate, 250 ng / mL FGF2 stem cell. The intestinal stem cell-like cells treated with recombinant human activin A and FGF2 were detached with Accutase, and seeded on GFR Matrigel diluted 30 times in human iPS medium. After inoculation, contain 2% FBS, 0.1mM NEAA, 2mM L-Glu, 100 units / mL penicillin G, 100μg / mL streptomycin sulfate, 2% B27 supplement, 1% N2supplement, 1% ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com